Shuttle Pharmaceuticals Dismisses Forvis Mazars as Auditor

Bitget2026/10/22 20:37

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Shuttle Pharmaceuticals will dismiss auditor Forvis Mazars under a decision approved by its board on October 16, 2026.
The dismissal takes effect following filing of the quarterly report for the period ended September 30, 2026.
Forvis Mazars’ audit reports for 2025 and 2024 flagged substantial doubt about the company’s ability to continue as a going concern.
Disclosed material weaknesses covered financial reporting controls, IT controls and insufficient technical accounting expertise for complex transactions.
No accounting or auditing disagreements arose during 2025, 2024 or the subsequent interim period through October 16, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shuttle Pharmaceuticals Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-048112), on October 22, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Shuttle Pharmaceuticals Dismisses Forvis Mazars as Auditor

You may also like

Crypto prices